# RLBP1

## Overview
The RLBP1 gene encodes the cellular retinaldehyde-binding protein 1 (CRALBP), a crucial component of the visual cycle in humans. CRALBP is a member of the CRAL-TRIO lipid-binding protein family and plays a significant role in the conversion of all-trans-retinal to 11-cis-retinal, a process essential for the regeneration of visual pigments and the maintenance of photoreceptor function (Liu2005Structural; Xue2015CRALBP). This protein is predominantly expressed in the retinal pigment epithelium and Müller cells, where it facilitates chromophore production and protects retinoids from damage (Xue2015CRALBP; Lima2020Effects). Mutations in the RLBP1 gene are associated with several autosomal recessive retinal dystrophies, highlighting its importance in visual health and disease (Schlegel2021Disturbed).

## Structure
The RLBP1 gene encodes the cellular retinaldehyde-binding protein (CRALBP), which is crucial in the human visual cycle. CRALBP is a member of the CRAL-TRIO lipid-binding protein family and shares 20-33% sequence identity with other family members (Liu2005Structural). The protein structure includes an N-terminal all-helical domain and a C-terminal domain characterized by a β-α-β-α-β-α-β fold. The ligand-binding cavity is located in the C-terminal domain, with a parallel β-sheet forming the floor and α-helices forming the sides (Liu2005Structural).

CRALBP can exist in two conformations: open and closed. The open conformation is associated with ligand binding and release, while the closed conformation is more stable and protects the ligand from the cellular environment (Liu2005Structural). The lipid-exchange loop, conserved among CRAL-TRIO proteins, can exist in open and closed conformations, indicating different functional states (Liu2005Structural). The closed conformation forms an α-helix, while the open form exposes a hydrophobic patch (Liu2005Structural).

Mutations in the RLBP1 gene, such as R234W, affect the binding cavity's volume and ligand mobility, impacting the protein's function in the visual cycle (Helbling2013Cellular).

## Function
The RLBP1 gene encodes the cellular retinaldehyde-binding protein (CRALBP), which plays a crucial role in the visual cycle, particularly in the retina. CRALBP is involved in the conversion of all-trans-retinal to 11-cis-retinal, a process essential for regenerating visual pigments and maintaining photoreceptor function. This protein acts as an acceptor of 11-cis-retinol and facilitates its oxidation to 11-cis-retinal, which is necessary for both rod and cone vision (Xue2015CRALBP; Vogel2007Identification; Lima2020Effects).

CRALBP is expressed in the retinal pigment epithelium (RPE) and Müller cells, where it supports the visual cycle by accelerating chromophore production, crucial for normal cone function and dark adaptation (Xue2015CRALBP; Lima2020Effects). It also acts as a chaperone for 11-cis-retinal, protecting against damage from free aldehyde and ensuring efficient production of 11-cis-retinol (Lima2020Effects).

In healthy human cells, CRALBP's function involves dynamic binding and transport of retinoids, with its conformational states playing a key role in its activity (Liu2005Structural). This protein is essential for maintaining normal visual function and preventing retinal diseases associated with its deficiency (Lima2020Effects).

## Clinical Significance
Mutations in the RLBP1 gene, which encodes the cellular retinaldehyde-binding protein (CRALBP), are linked to several autosomal recessive retinal dystrophies. These include retinitis punctata albescens (RPA), Bothnia dystrophy, Newfoundland rod-cone dystrophy, and fundus albipunctatus. These conditions are characterized by symptoms such as night blindness, prolonged dark adaptation, and progressive vision loss, often leading to central vision impairment and legal blindness by ages 20-40 (Schlegel2021Disturbed; Lima2020Effects).

RPA, a subtype of retinitis pigmentosa, is marked by white fleck-like deposits in the fundus and is often caused by pathogenic variants in the RLBP1 gene. Patients with RPA typically experience night blindness and progressive macular degeneration (TorresCosta2020A). Bothnia dystrophy and Newfoundland rod-cone dystrophy also result from RLBP1 mutations, with similar clinical manifestations (Green2020Qualitative).

Gene therapy trials for RLBP1-associated retinal dystrophy have shown promise, with improvements in dark adaptation and visual function following treatment. However, challenges remain, such as dose-dependent intraocular inflammation and retinal atrophy (Kvanta2024Interim). These findings underscore the clinical significance of RLBP1 in retinal health and disease.

## Interactions
The RLBP1 gene encodes the cellular retinaldehyde-binding protein (CRALBP), which is involved in several critical interactions within the visual cycle. CRALBP primarily interacts with 11-cis-retinol dehydrogenase (RDH5) and ERM-binding phosphoprotein 50 (EBP50). These interactions suggest a mechanism for localizing CRALBP to the retinal pigment epithelium (RPE) plasma membrane, facilitating the export of 11-cis-retinal to rod photoreceptor cells for visual pigment regeneration (Liu2005Structural).

CRALBP also interacts with RPE65, an enzyme crucial for the isomerization of all-trans retinyl esters to 11-cis retinol, a process essential for the visual cycle. This interaction is vital for the regeneration of the visual chromophore 11-cis retinal following light absorption (Damodar2024Dual). Additionally, CRALBP binds tightly to its substrates, 11-cis-retinal and 11-cis-retinol, within a hydrophobic cavity, protecting them from premature isomerization and enzymatic back transformation (Helbling2014Mechanisms).

Mutations in RLBP1, such as the R234W substitution, can alter these interactions by affecting the binding cavity size, leading to tighter binding of 11-cis-retinal and potentially impacting its release (Helbling2014Mechanisms). These interactions are crucial for maintaining visual function and retinal health.


## References


[1. (Kvanta2024Interim) Anders Kvanta, Nalini Rangaswamy, Karen Holopigian, Christine Watters, Nicki Jennings, Melissa S. H. Liew, Chad Bigelow, Cynthia Grosskreutz, Marie Burstedt, Abinaya Venkataraman, Sofie Westman, Asbjörg Geirsdottir, Kalliopi Stasi, and Helder André. Interim safety and efficacy of gene therapy for rlbp1-associated retinal dystrophy: a phase 1/2 trial. Nature Communications, September 2024. URL: http://dx.doi.org/10.1038/s41467-024-51575-4, doi:10.1038/s41467-024-51575-4. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-51575-4)

[2. (Green2020Qualitative) Jane Green, Chloe Tolley, Sarah Bentley, Rob Arbuckle, Marie Burstedt, James Whelan, Karen Holopigian, Kali Stasi, Brigitte Sloesen, Claudio Spera, Jean-Yves Deslandes, and Anmol Mullins. Qualitative interviews to better understand the patient experience and evaluate patient-reported outcomes (pro) in rlbp1 retinitis pigmentosa (rlbp1 rp). Advances in Therapy, 37(6):2884–2901, May 2020. URL: http://dx.doi.org/10.1007/s12325-020-01275-4, doi:10.1007/s12325-020-01275-4. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12325-020-01275-4)

[3. (Liu2005Structural) Tianyun Liu, Ekachai Jenwitheesuk, David C. Teller, and Ram Samudrala. Structural insights into the cellular retinaldehyde‐binding protein (cralbp). Proteins: Structure, Function, and Bioinformatics, 61(2):412–422, August 2005. URL: http://dx.doi.org/10.1002/prot.20621, doi:10.1002/prot.20621. This article has 19 citations.](https://doi.org/10.1002/prot.20621)

[4. (Schlegel2021Disturbed) Domino K Schlegel, Srinivasagan Ramkumar, Johannes von Lintig, and Stephan CF Neuhauss. Disturbed retinoid metabolism upon loss of rlbp1a impairs cone function and leads to subretinal lipid deposits and photoreceptor degeneration in the zebrafish retina. eLife, October 2021. URL: http://dx.doi.org/10.7554/elife.71473, doi:10.7554/elife.71473. This article has 9 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.71473)

[5. (Helbling2014Mechanisms) Rachel E. Helbling, Christos Lamprakis, Walter Aeschimann, Cristin S. Bolze, Achim Stocker, and Michele Cascella. Mechanisms of ligand–protein interaction in sec-14-like transporters investigated by computer simulations. CHIMIA, 68(9):615, September 2014. URL: http://dx.doi.org/10.2533/chimia.2014.615, doi:10.2533/chimia.2014.615. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.2533/chimia.2014.615)

[6. (Helbling2013Cellular) Rachel E. Helbling, Christin S. Bolze, Marcin Golczak, Krzysztof Palczewski, Achim Stocker, and Michele Cascella. Cellular retinaldehyde binding protein—different binding modes and micro-solvation patterns for high-affinity 9-cis- and 11-cis-retinal substrates. The Journal of Physical Chemistry B, 117(37):10719–10729, September 2013. URL: http://dx.doi.org/10.1021/jp405410t, doi:10.1021/jp405410t. This article has 4 citations.](https://doi.org/10.1021/jp405410t)

[7. (Lima2020Effects) Jose Ronaldo Lima de Carvalho, Hye Jin Kim, Keiko Ueda, Jin Zhao, Aaron P. Owji, Tingting Yang, Stephen H. Tsang, and Janet R. Sparrow. Effects of deficiency in the rlbp1-encoded visual cycle protein cralbp on visual dysfunction in humans and mice. Journal of Biological Chemistry, 295(19):6767–6780, May 2020. URL: http://dx.doi.org/10.1074/jbc.ra120.012695, doi:10.1074/jbc.ra120.012695. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra120.012695)

[8. (Xue2015CRALBP) Yunlu Xue, Susan Q. Shen, Jonathan Jui, Alan C. Rupp, Leah C. Byrne, Samer Hattar, John G. Flannery, Joseph C. Corbo, and Vladimir J. Kefalov. Cralbp supports the mammalian retinal visual cycle and cone vision. Journal of Clinical Investigation, 125(2):727–738, January 2015. URL: http://dx.doi.org/10.1172/jci79651, doi:10.1172/jci79651. This article has 98 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci79651)

[9. (Vogel2007Identification) John S. Vogel, Elizabeth C. Bullen, Crystal L. Teygong, and Eric W. Howard. Identification of therlbp1gene promoter. Investigative Opthalmology &amp; Visual Science, 48(8):3872, August 2007. URL: http://dx.doi.org/10.1167/IOVS.06-1523, doi:10.1167/iovs.06-1523. This article has 13 citations.](https://doi.org/10.1167/IOVS.06-1523)

[10. (TorresCosta2020A) Sónia Torres-Costa, Carla Sofia Ferreira, Ana Grangeia, Renato Santos-Silva, Elisete Brandão, Sérgio Estrela-Silva, and Fernando Falcão-Reis. A novel homozygous frameshift variant in the cellular retinaldehyde-binding protein 1 (rlbp1) gene causes retinitis punctata albescens. European Journal of Ophthalmology, 31(3):NP74–NP80, April 2020. URL: http://dx.doi.org/10.1177/1120672120919064, doi:10.1177/1120672120919064. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/1120672120919064)

11. (Damodar2024Dual) Dual CRALBP isoforms unveiled: iPSC-derived retinal modelling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy. This article has 0 citations.